3:42AM ET 5/13/2022 MT NewswiresNeurocrine Biosciences (NBIX) said late Thursday the US Food and Drug Administration granted an orphan drug designation to valbenazine for the potential...
5:41PM ET 5/11/2022 MT NewswiresRichard F Pops, Director, on May 09, 2022, sold 15,000 shares in Neurocrine Biosciences (NBIX) for $1,144,463. Following the Form 4 filing with the SEC,...
12:39PM ET 5/04/2022 MT NewswiresExpected Earnings Release: 05/04/2022, After-hours Avg. Extended-Hours Dollar Volume: $11,976,203 Neurocrine Biosciences (NBIX) is due to issue its...
11:45AM ET 5/04/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...